Document is current
Any future updates will be listed below
-
Authors
Kitaoka, Kaori
Kaneko, Hidehiro
Suzuki, Yuta
Okada, Akira
Mizuno, Atsushi
Fujiu, Katsuhito
Takeda, Norifumi
Morita, Hiroyuki
Azegami, Tatsuhiko
Hayashi, Kaori
Node, Koichi
Furui, Yuji
Miura, Katsuyuki
Yasunaga, Hideo
Takeda, Norihiko
- License Information
-
More Information
Article History
Received: 19 November 2024
Revised: 18 June 2025
Accepted: 23 June 2025
First Online: 25 July 2025
Compliance with ethical standards
:
: Research funding and scholarship funds (HK and KF) from Medtronic Japan Co., LTD, Boston Scientific Japan Co., LTD, BIOTRONIK JAPAN INC, and SIMPLEX QUANTUM Inc. HK holds shares in PrevMed Co., Ltd. and Japan Preventive Medical Development Institute Co., Ltd. NT received research funding from Kyowa Kirin Co Ltd; research funding from Bristol Myers Squibb Japan. KN received honoraria from AstraZeneca, Bayer, Boehringer Ingelheim Japan, Daiichi Sankyo, Eli Lilly Japan, Kowa, Mitsubishi Tanabe, MSD, Novartis, Novo Nordisk, and Otsuka; research funding from Astellas, Bayer, Boehringer Ingelheim Japan, Fuji Yakuhin, Mochida, and Novartis; and scholarships from Abbott Medical, Boehringer Ingelheim Japan, Daiichi Sankyo Healthcare, Mitsubishi Tanabe, and Teijin.
: Name of the ethics committee: the Clinical Research Review Board of The University of Tokyo [2018-10862].
